Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1960 1
1961 2
1963 4
1964 3
1965 1
1966 3
1967 4
1971 2
1972 2
1974 1
1975 3
1980 2
1981 3
1982 2
1983 8
1984 6
1985 9
1986 10
1987 24
1988 15
1989 18
1990 10
1991 9
1992 12
1993 14
1994 10
1995 15
1996 16
1997 33
1998 26
1999 30
2000 23
2001 20
2002 27
2003 45
2004 49
2005 55
2006 62
2007 81
2008 80
2009 99
2010 103
2011 128
2012 147
2013 126
2014 139
2015 131
2016 121
2017 124
2018 127
2019 152
2020 166
2021 31
Text availability
Article attribute
Article type
Publication date

Search Results

2,095 results
Results by year
Filters applied: . Clear all
Page 1
MCL-1 inhibition in cancer treatment.
Xiang W, Yang CY, Bai L. Xiang W, et al. Among authors: yang cy. Onco Targets Ther. 2018 Oct 23;11:7301-7314. doi: 10.2147/OTT.S146228. eCollection 2018. Onco Targets Ther. 2018. PMID: 30425521 Free PMC article. Review.
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.
Wang CW, Yang LY, Chen CB, Ho HC, Hung SI, Yang CH, Chang CJ, Su SC, Hui RC, Chin SW, Huang LF, Lin YY, Chang WY, Fan WL, Yang CY, Ho JC, Chang YC, Lu CW, Chung WH; the Taiwan Severe Cutaneous Adverse Reaction (TSCAR) Consortium. Wang CW, et al. Among authors: yang cy. J Clin Invest. 2018 Mar 1;128(3):985-996. doi: 10.1172/JCI93349. Epub 2018 Feb 5. J Clin Invest. 2018. PMID: 29400697 Free PMC article. Clinical Trial.
2,095 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page